Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ginkgo-biloba-Blätter-Trockenextrakt, (OBG) ATC N06DP01 für die Zeit 01.01.2025 - 31.12.2026
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ginkgo-biloba-Blätter-Trockenextrakt, (OBG) ATC N06DP01…”. Bids close on 5 November 2026.
The work
Framework agreement for non-exclusive discount contracts for Ginkgo-biloba-Blätter-Trockenextrakt (ATC N06DP01) for the period 01.01.2025 - 31.12.2026.
- contracts are concluded for the specified active substance
- contracts end automatically with the entry into force of an exclusive contract
Key facts
- Contract period
- 01.01.2025 - 31.12.2026
- Evaluation
- no formal evaluation process as it is a non-exclusive framework agreement for all interested companies
What it takes to qualify
Worth a closer look
- The document is a notice for a non-exclusive framework agreement, not a standard public tender. The process is described as a 'Zulassungsverfahren' (registration procedure) rather than a formal 'Vergabeverfahren' (procurement procedure).
- The document states it is not a public procurement under cartel law, but uses the 'Offene Verfahren' form for technical reasons.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Angebotsschreibensubmitted with the offer
- Anerkennung der vertraglichen Maßgabenby submitting the contract with name or company stamp
- Anlage 1 zum Vertragto be filled out and submitted
- Anlage 2 zum Vertragto be filled out and submitted as an Excel file
- Eigenerklärung des Unternehmensthat no exclusion criteria under §§ 123 and 124 GWB apply